Home › Chronic Inflammatory Demyelinating Polyradiculoneuropathy › Michigan
Chronic Inflammatory Demyelinating Polyradiculoneuropathy clinical trials in Michigan
5 studies for Chronic Inflammatory Demyelinating Polyradiculoneuropathy are looking for participants at sites in Michigan.
Imeroprubart in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- Site Number - 1629, Detroit
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT07032662A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP
- University of Michigan Hospital, Ann Arbor
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT06920004A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- Henry Ford Hospital- Site Number : 8400025, Detroit
- Michigan State University- Site Number : 8400038, East Lansing
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT06290141A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders
- TG Therapeutics Investigational Trial Site, Ann Arbor
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT06680037A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)
- Clinical Study Site, East Lansing
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Sep 2, 2026 · NCT06858579From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.